Association between ceramides and coronary artery stenosis in patients with coronary artery disease

Table 2 Association between plasma ceramides and the severity of coronary stenosis after adjustment of multiple risk factors

Logistic Stepwise Regression Analyses	Effect	β	P	Odds Ratio	95% Confidence Interval
Model 1^a	Gender (male vs female)	−0.472	0.001	2.57	1.446–4.567
	HbA1c%	0.315	0.042	1.37	1.012–1.854
	Cer (d18:0/24:1)/Cer (d18:0/24:0)	2.941	0.012	18.927	1.902–188.380
	Diagnosis UAP vs atherosclerosis	0.733	0.069	62.903	19.586–202.016
	Diagnosis AMI vs atherosclerosis	2.676	< 0.001	439.227	45.285- > 999.999
Model 2^a	Gender (male vs female)	0.480	0.003	2.609	1.401–4.859
	Hypertension (yes vs. no)	−0.235	0.121	0.625	0.346–1.131
	HDL cholesterol	−0.888	0.098	0.412	0.144–1.177
	LDL cholesterol	0.467	0.03	1.579	1.046–2.384
	HbA1c%	0.242	0.129	1.273	0.932–1.739
	Cer (d18:0/24:1)/Cer (d18:0/24:0)	3.225	0.008	25.152	2.360–268.084
	Diagnosis UAP vs atherosclerosis	0.806	0.049	70.024	21.017–233.300
	Diagnosis AMI vs atherosclerosis	2.637	< 0.001	436.9.8	44.311- > 999.999

^aadjustment factor.model 1: gender, age, smoking, prior MI/CI, current diagnosis, HbA1c%. model 2: gender, age, smoking, prior MI/CI, the presence of hypertension, current diagnosis, HbA1c%, TC, HDL-C, LDL-C. entry and exit criteria were 0.2 for stepwise selection

ISSN: 1476-511X